Lunai Bioworks Inc. Debt Instrument, Face Amount
Lunai Bioworks Inc. (LNAI) had Debt Instrument, Face Amount of $308.00 thousand as of 2026-02-12, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-05-15
- 2026-02-12: Debt Instrument, Face Amount $308.00K.
- 2025-02-07: Debt Instrument, Face Amount $4.00M.
- 2025-01-24: Debt Instrument, Face Amount $900.00K.
- 2024-11-06: Debt Instrument, Face Amount $900.00K.
USD
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2026-02-12 | $308.00K 10-Q · filed 2026-05-15 |
| 2025-02-07 | $4.00M 10-Q · filed 2025-02-19 |
| 2025-01-24 | $900.00K 10-Q · filed 2025-02-19 |
| 2024-11-06 | $900.00K 10-Q/A · filed 2025-02-19 |
| 2023-12-31 | $560.00K 10-Q · filed 2024-02-14 |
| 2023-10-05 | $2.11M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $789.47K 10-Q · filed 2023-11-14 |
| 2023-09-29 | $789.47K 10-Q · filed 2023-11-14 |
| 2023-09-05 | $789.47K 10-Q · filed 2023-11-14 |
| 2013-12-16 | $1.50M 10-KT · filed 2015-09-28 |
| 2011-12-01 | $1.50M 10-KT · filed 2015-09-28 |
EUR
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2024-12-03 | 50.00K EUR 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |